Intracranial structure hemangioma is a rare, usually benign growth made of blood vessels inside the skull or nearby brain structures. Early symptoms of intracranial structure hemangioma can include headaches, seizures, vision changes, or other nerve-related problems, but some cause no symptoms and are found on imaging. It can affect both adults and children, and how long it lasts often depends on its size, location, and whether it grows or bleeds. Not everyone will have the same experience. Treatment may include monitoring, surgery, and sometimes focused radiation, and the risk to life is often low unless the hemangioma causes pressure, bleeding, or is in a critical area.
How many people live with Intracranial structure hemangioma?
Intracranial structure hemangioma is considered very rare, but there is no widely accepted, up-to-date estimate for how many people are living with it worldwide or in the United States. Published medical information mainly comes from individual case reports and small case series, so a reliable global or U.S. population count is not available.
Overview
Intracranial structure hemangiomaSymptoms
Intracranial structure hemangioma may cause headaches, seizures, or balance problems. Some people have vision changes, weakness, or numbness if nearby brain tissue is affected. Early symptoms of intracranial structure hemangioma can vary with its size and location.
Outlook and prognosis
Outlook for intracranial structure hemangioma is often good, especially when it is small, found early, and can be monitored or treated. Prognosis depends mainly on its size and location, since growth or bleeding can affect nearby brain tissue.
Causes and risk factors
Intracranial structure hemangioma usually develops from abnormal blood vessel growth, often before birth. The exact cause is often unclear, but some cases relate to genetic changes, while hormones, age, and location may affect growth or symptoms.
Genetic influences
Genetics do not appear to play a major role in intracranial structure hemangioma. Most cases seem sporadic rather than inherited, though rare genetic influences may be found in some people.
Diagnosis
Diagnosis of intracranial structure hemangioma usually starts with brain imaging, often MRI and sometimes CT. Doctors combine imaging findings with symptoms and may confirm the diagnosis with pathology after surgery or, less often, a biopsy.
Treatment and drugs
Treatment for intracranial structure hemangioma depends on size, location, and symptoms. Many living with intracranial structure hemangioma need regular brain scans and symptom control, such as seizure medicine. Surgery may help if bleeding, pressure, or repeated symptoms occur.
Symptoms
Intracranial structure hemangioma can go unnoticed for a while, especially when it is small. The changes are often subtle at first, blending into daily life until they become more noticeable. When symptoms do appear, they usually come from pressure on nearby brain tissue, irritation of the brain, or less often bleeding. Because early symptoms of intracranial structure hemangioma can be mild or vague, what you notice depends a lot on its size and exact location.
Headaches are one of the most common symptoms and may become more frequent or more intense over time. Some people notice pain that feels worse in the morning, with coughing, or when bending over.
Seizures can happen if the lesion irritates nearby brain tissue. They may look like shaking, staring spells, sudden confusion, or brief loss of awareness.
Blurred vision, double vision, or loss of part of the visual field can occur when areas linked to sight are affected or pressure rises inside the skull. Some may also notice trouble focusing or abnormal eye movements.
Pressure on parts of the brain that control movement or sensation can cause weakness, numbness, or tingling, often on one side of the body. Everyday tasks like buttoning a shirt or carrying groceries may suddenly feel harder.
How people usually first notice Intracranial structure hemangioma?
How intracranial structure hemangioma is first noticed often depends on its size and exact location in the brain or nearby tissues: many people first learn about it after headaches, seizures, dizziness, vision changes, or weakness on one side of the body lead to a brain scan. In some cases, there are no clear warning signs at all, and the hemangioma is found by chance during imaging done for another reason. For many living with this condition, the first signs of intracranial structure hemangioma come from pressure on nearby brain structures or from bleeding, which is why new neurologic symptoms should be checked promptly.
Types of Intracranial structure hemangioma
Intracranial structure hemangioma can affect daily life in different ways depending on the exact kind of blood vessel growth and where it is located. Symptoms don’t always look the same for everyone. In practice, the main types of intracranial structure hemangioma are usually described by the way the blood vessels are formed, and that can change whether someone has headaches, seizures, vision changes, or no symptoms at all. Some are found after new neurologic symptoms appear, while others turn up by chance on brain imaging.
Cavernous hemangioma
This type is made up of clusters of widened blood-filled spaces, and it is the form most often linked with seizures, headaches, or small bleeds in the brain. Some people have no symptoms, while others may notice sudden problems such as weakness, numbness, or trouble speaking if the lesion irritates nearby brain tissue. Symptoms can vary a lot based on size and location.
Capillary hemangioma
This rarer type is made of many very small blood vessels packed closely together, and it may act more like a slow-growing mass than a bleeding-prone lesion. For many living with intracranial structure hemangioma, symptoms from this variant depend mainly on pressure on nearby structures, which can lead to headaches, vision changes, or balance problems. In infants and children, signs may sometimes be noticed earlier because the lesion can affect normal development or feeding.
Can I slow down the onset of symptoms?
Usually no. For an intracranial hemangioma, there is no good evidence that diet, exercise, sleep, supplements, or other lifestyle changes can meaningfully delay when symptoms start; symptoms are more often linked to where the growth is, whether it gets bigger, and whether it bleeds. There is also no well-established medicine to prevent symptoms before they begin, although some people may be followed with regular scans and specialist visits so changes can be picked up early, and while research is ongoing, the main goal is careful monitoring and timely treatment rather than prevention.
What genetics can tell you about symptoms
For most people with an intracranial hemangioma, genetics does not clearly predict which symptoms will happen, how severe they will be, or exactly when they will start, because these growths are usually sporadic rather than strongly inherited. In rare cases, an inherited condition that affects how blood vessels grow can make similar lesions more likely or lead them to appear earlier, and that can shape symptoms indirectly by changing the number, size, or location of the lesion. In day-to-day care, symptoms are usually driven much more by where the hemangioma is in the brain and whether it presses on nearby tissue or bleeds than by a specific genetic finding.
Causes and risk factors
Intracranial structure hemangioma often starts when a small group of blood vessels grows or forms abnormally. This can happen before birth, and in some cases it is linked to inherited or new gene changes that affect blood vessel growth. Having a gene change doesn’t mean you’ll definitely develop the condition. Prior radiation to the head may raise risk, and age, sex, or hormone changes may also play a part in when symptoms show up. Smoking, diet, and exercise are not known to directly cause intracranial structure hemangioma, and some people are diagnosed before any early symptoms of intracranial structure hemangioma appear.
What are the most common causes or risk factors?
The exact cause of an intracranial structure hemangioma, a blood-vessel growth inside the skull, is often not clear, but many seem to happen when blood vessels develop in an unusual way, sometimes before birth. In some families, an inherited tendency can raise the risk, and some types are seen more often in women, which suggests hormones may also play a part. There are no well-proven lifestyle causes, and most people living with this condition did nothing to cause it.
Environmental and biological risk factors
Intracranial structure hemangioma is rare, and the exact cause is often not clear. The known risk factors for intracranial structure hemangioma mostly relate to how blood vessels form before birth and to certain pregnancy or birth factors. Doctors often group risks into internal (biological) and external (environmental).
Hemangiomas overall are seen more often in females than in males. This pattern has also been reported in rare intracranial forms, although the condition is uncommon and data are limited.
Being born preterm or at a very low birth weight has been linked with hemangiomas more broadly. For intracranial structure hemangioma, these early birth factors may reflect differences in blood vessel development before birth.
Problems involving the placenta, including reduced placental blood flow, have been linked with a higher chance of hemangiomas. Multiple pregnancy, such as twins or triplets, may raise this risk because placental stresses are more common.
Older maternal age has been associated with a higher chance of hemangiomas in some studies. This is only one factor among many, and most pregnancies in this age group do not lead to intracranial structure hemangioma.
Genetic risk factors
The best-studied genetic causes of intracranial structure hemangioma involve the familial cavernous type, where a tendency to form these blood vessel lesions runs in families. Many people have a single lesion with no clear inherited cause, but multiple lesions or several affected relatives make an inherited form more likely. Carrying a genetic change doesn’t guarantee the condition will appear. That is why the inherited risk of intracranial structure hemangioma can look different even within the same family.
Family history: A family pattern is one of the clearest genetic risk factors for intracranial structure hemangioma. If a parent carries the inherited form, each child has a 1 in 2 chance of inheriting the gene change. Even within one family, symptoms can vary a lot.
KRIT1 change: Changes in the KRIT1 gene are a well-known cause of the familial form of intracranial structure hemangioma. Many people with this gene change develop more than one lesion over time, although some have few or no symptoms.
CCM2 change: Changes in the CCM2 gene can also cause inherited intracranial structure hemangioma. Some families with CCM2 have multiple lesions seen on scans, even when some relatives feel completely well.
PDCD10 change: Changes in the PDCD10 gene are less common, but they can be linked with earlier onset and a larger number of lesions in some families. Severity still varies, so one relative may have major symptoms while another has none.
New mutation: Sometimes the gene change starts for the first time in one person, with no prior family history. That person can still pass the change on to their children.
Multiple lesions: When scans show several intracranial structure hemangioma lesions, an inherited cause becomes more likely. This pattern often prompts doctors to ask about relatives and consider genetic testing.
Lifestyle risk factors
An intracranial structure hemangioma is not caused by lifestyle habits, but daily habits can influence symptoms, bleeding risk, headache burden, seizure control, and recovery after treatment. In practice, how lifestyle affects intracranial structure hemangioma depends on its size, location, and whether it has caused prior bleeding or neurologic symptoms. The most relevant factors are those that change blood pressure, injury risk, sleep quality, and overall brain health.
Poorly controlled high blood pressure may increase stress on fragile blood vessels and can raise concern for bleeding or worsening neurologic symptoms. Following a plan that supports stable blood pressure, including limiting excess salt and taking prescribed medicines, may help reduce strain on the lesion.
Smoking damages blood vessels and reduces oxygen delivery to brain tissue, which can complicate recovery and worsen overall cerebrovascular health. Quitting smoking may lower the chance of added vascular problems in someone already living with an intracranial hemangioma.
Heavy alcohol use can worsen headaches, disrupt balance and judgment, and may increase seizure risk in people prone to seizures. It can also interfere with sleep and with medicines used for pain, seizures, or blood pressure control.
Cocaine, amphetamines, and other stimulants can sharply raise blood pressure and may increase the risk of sudden neurologic events. Avoiding recreational drugs is especially important when a brain vascular lesion is present.
Risk prevention
For most people, there is no proven way to prevent intracranial structure hemangioma itself, because these growths usually are not caused by something you did or did not do. Prevention is mostly about lowering the chance of complications, spotting changes early, and protecting overall brain and blood vessel health. Different people need different prevention strategies—there’s no single formula.
Scheduled check-ups and brain imaging can help catch growth, bleeding, or pressure changes before they cause bigger problems. This is especially important if a hemangioma has already been found and is being watched over time.
Learning the early symptoms of intracranial hemangioma, such as new headaches, seizures, weakness, vision changes, or sudden balance problems, can help you seek care quickly. Fast evaluation matters because some symptoms may signal bleeding or pressure on nearby brain tissue.
Using seat belts, wearing a helmet for biking or contact sports, and lowering fall risk at home may help protect the brain from trauma. While this does not prevent the hemangioma itself, it can reduce the chance of injury-related complications.
Talk with your doctor before using blood thinners, aspirin, or supplements that can raise bleeding risk, especially if you already have a known lesion. Never stop a prescribed medicine on your own, because the safest plan depends on your full health picture.
Can you prevent Intracranial structure hemangioma?
Usually, no, intracranial structure hemangioma cannot be prevented because it is a rare growth made of blood vessels, and its exact cause is often unclear. There are no well-proven lifestyle changes, diets, or medicines that can stop it from developing. If it is linked to a family pattern or another health condition, regular medical follow-up may help find problems early, but it does not prevent the growth itself.
Transmission
Intracranial structure hemangioma is not infectious, so it cannot be passed from one person to another through touch, coughing, kissing, sex, blood, or shared food and drink. Many living with intracranial structure hemangioma develop it sporadically, meaning it usually happens by chance rather than being clearly passed down in a family.
When people ask about how intracranial structure hemangioma is inherited, the short answer is that most cases are not linked to a parent-to-child pattern. In some situations, doctors may look more closely at family history or related vessel conditions, but for most people this condition is not considered contagious and is not strongly hereditary.
When to test your genes
Genetic testing is not routine for an intracranial hemangioma, because most are diagnosed by imaging and are not tied to a single inherited cause. It may be worth discussing if you or close relatives have multiple vascular birthmarks, other unusual blood vessel problems, or features of a broader genetic syndrome.
Diagnosis
Intracranial structure hemangioma is usually diagnosed after symptoms such as headaches, seizures, vision changes, or other nerve-related problems lead to brain imaging. In some people, it is found by chance during a scan done for another reason. Doctors usually confirm the diagnosis by combining the scan pattern, the location of the growth, and the person’s medical history. Some diagnoses are clear after a single visit, while others take more time.
Doctors ask about symptoms, when they started, and whether they are getting worse or coming and going. This helps shape the diagnosis of intracranial structure hemangioma and can show how urgently testing is needed.
A doctor checks strength, balance, reflexes, vision, speech, and other brain and nerve functions. Changes on the exam can help show which part of the brain may be affected.
MRI is often the main test because it shows soft tissues in great detail and can reveal the size and exact position of the lesion. Contrast dye is often used to see how the blood vessel growth behaves and whether nearby tissue is affected.
CT can help detect bleeding, calcium, or pressure on nearby brain structures. It may be used when symptoms start suddenly or when MRI is not available right away.
How is Intracranial structure hemangioma diagnosed?
Doctors usually diagnose an intracranial hemangioma, which is a noncancerous growth made of blood vessels inside the skull, with imaging tests such as an MRI or CT scan, because these pictures can show where it is, how big it is, and whether it is pressing on nearby brain tissue. They also use your symptoms, medical history, and a nervous system exam, and in some cases a special blood vessel scan called an angiogram may help confirm what is being seen. Genetic testing is not usually needed to diagnose this condition, but it may be considered if doctors think it is part of a broader inherited condition.
Stages of Intracranial structure hemangioma
Intracranial structure hemangioma does not have defined progression stages. This is because it is usually identified as a specific blood-vessel growth seen on brain imaging, rather than a condition that moves through clear step-by-step phases over time. Often the process begins when you notice changes in daily life, such as headaches, seizures, or trouble with vision or balance, although some people have no symptoms and the finding shows up by chance on a scan. Diagnosis and follow-up usually rely on symptoms, a neurological exam, and imaging tests such as MRI or CT scans, which also help doctors judge whether early symptoms of intracranial structure hemangioma are linked to the lesion and whether it is staying stable.
Outlook and prognosis
The outlook for intracranial structure hemangioma is often favorable because these lesions are usually benign and slow growing, but prognosis depends strongly on the exact location, size, and whether they can be safely removed or controlled. Many people do very well after complete surgical excision, with good long-term symptom control and a low risk of recurrence, while others may be monitored if the lesion is small and not causing problems. When the hemangioma is in or near critical brain structures, the main threats to outcome are bleeding, seizures, pressure on nearby tissue, and lasting neurologic deficits rather than cancer-like spread. In selected cases, stereotactic radiosurgery or other targeted treatment can help stabilize residual or difficult-to-reach lesions. Overall mortality appears low for successfully treated cases, but life-threatening complications can occur if there is significant intracranial hemorrhage, brainstem involvement, or major surgical complications. Long-term follow-up imaging is often recommended because even benign lesions can occasionally regrow or cause delayed symptoms.
Long-term effects
For many, the long-term picture with intracranial structure hemangioma depends most on where the growth sits in the brain or nearby structures, how large it is, and whether it causes pressure or bleeding. Some people live for years with few lasting problems, while others have ongoing effects related to seizures, headaches, vision, balance, or nerve function. Thinking about the long-term effects helps explain why follow-up imaging and neurologic checks may continue even after treatment. It’s important to remember that long-term doesn’t always mean progressive, but changes can happen over time.
Some people with intracranial structure hemangioma have repeated seizures if the area irritates nearby brain tissue. This can affect driving, work, school, and day-to-day independence even when the growth itself is stable.
Ongoing headaches can remain a long-term issue, especially if there has been pressure on nearby structures or prior bleeding. Many living with intracranial structure hemangioma describe flare-ups that interrupt sleep, concentration, or routine activities.
Some hemangiomas can bleed into surrounding tissue, and the effects may range from mild to serious depending on the location and amount of bleeding. Even a small bleed can leave lasting symptoms such as weakness, numbness, or trouble speaking.
If the hemangioma presses on nearby nerves, long-term problems can include vision changes, hearing changes, facial weakness, or trouble with swallowing. These effects may improve, stay the same, or persist after treatment, depending on how long the nerve was affected.
How is it to live with Intracranial structure hemangioma?
Living with an intracranial structure hemangioma can range from almost no day-to-day impact to a life shaped by headaches, seizures, balance problems, vision changes, or fatigue, depending on where the growth sits in the brain and whether it presses on nearby tissue. For many people, daily life also includes regular brain scans, follow-up visits, and the stress of not always knowing if the hemangioma will stay quiet or start causing more trouble. Family members and other close supports may need to help with transportation, appointments, medication routines, or safety planning if symptoms affect driving, work, school, or independent living.
Treatment and drugs
Treatment for intracranial structure hemangioma depends on where the growth is, how large it is, and whether it is causing problems such as headaches, seizures, bleeding, or pressure on nearby brain tissue. Some people with intracranial structure hemangioma only need regular scans and follow-up visits, while others may need treatment to prevent complications or relieve symptoms; medicines that ease symptoms are called supportive treatments and can include drugs for pain, swelling, or seizures. If the hemangioma is accessible and causing significant symptoms, surgery may be recommended, and in some cases focused radiation may be used when surgery is too risky or cannot remove the whole lesion. Not every treatment works the same way for every person, so care is usually planned by a team that may include a neurologist, neurosurgeon, and radiologist.
Can you cure Intracranial structure hemangioma?
There is not always a simple cure for an intracranial structure hemangioma, which is a usually noncancerous growth made of blood vessels in or around the structures inside the skull. If it can be safely removed completely, that may cure it, but some cannot be fully removed because of where they are. When a full cure is not possible or treatment is not needed right away, close follow-up, surgery, radiation, or sometimes medicine can help shrink it, stop growth, or ease symptoms.
Non-drug treatment
Treatment for intracranial structure hemangioma often depends on where the growth is, how large it is, and whether it is causing symptoms such as headaches, seizures, or pressure on nearby brain tissue. Some people only need careful monitoring, while others may need a procedure to lower bleeding risk or remove the lesion. Managing this condition often means combining specialist imaging, procedure-based care, and supportive therapies rather than relying on medicines alone. The best non-surgical treatment for intracranial structure hemangioma can vary from one person to another.
Small or symptom-free lesions may be watched with regular brain scans and follow-up visits. This helps the care team spot growth, bleeding, or new pressure on nearby structures before problems become more serious.
Surgery may be used when the hemangioma is causing symptoms, bleeding, or pressure on important brain areas. The goal is to remove as much of the lesion as is safely possible while protecting nearby tissue.
In some cases, highly targeted radiation such as stereotactic radiosurgery can be used when open surgery is risky or not possible. This approach aims to damage the abnormal blood vessels over time while limiting exposure to surrounding brain tissue.
An embolization procedure blocks blood flow to the hemangioma through a tiny tube placed inside a blood vessel. It may be used before surgery to reduce bleeding risk, or sometimes as part of treatment on its own.
Your genes may have an impact on how drugs work for you
For people living with an intracranial hemangioma, treatment is usually guided more by the growth’s size, location, and symptoms than by genetic testing. Even so, inherited differences can sometimes affect how the body breaks down medicines that may be used around care, such as pain medicines, anti-seizure medicines, or drugs that lower the chance of blood clots, which can mean one person gets good relief while another has more side effects or needs a different dose. At this time, there is no widely used gene-based medicine plan for this condition itself, so doctors usually adjust treatment by watching closely how someone responds.
Pharmacological treatments
Medicines are not usually the main treatment for intracranial structure hemangioma, because drugs often do not shrink or remove the growth itself. Instead, treatment usually focuses on easing symptoms, reducing swelling, or helping around surgery or radiation when those are needed. The exact medicines depend on where the hemangioma is, whether it has bled, and what symptoms are affecting daily life. Not everyone responds to the same medication in the same way.
If intracranial structure hemangioma is causing seizures, doctors may use anti-seizure drugs such as levetiracetam, lamotrigine, valproate, or lacosamide. These medicines help calm abnormal electrical activity in the brain, but they do not remove the hemangioma.
Corticosteroids such as dexamethasone may be used short term to reduce swelling around the lesion, especially if headaches, weakness, or pressure symptoms flare up. Sometimes medicines are taken short-term (acute treatment), while others are used long-term, and steroids are usually the short-term option because longer use can cause side effects.
Headaches linked to intracranial structure hemangioma may be treated with medicines such as acetaminophen or, in some cases, other prescription pain relievers. The right choice depends on bleeding risk and your overall health, so treatment for intracranial structure hemangioma should be tailored by a specialist.
In rare situations, other medicines may be considered based on age and hemangioma type, such as propranolol for certain infant hemangiomas under close specialist care. For many living with intracranial structure hemangioma, though, surgery or focused radiation matters more than drug treatment itself.
Genetic influences
Most intracranial structure hemangiomas do not seem to be strongly inherited, and many appear without a clear genetic cause in the family. It’s natural to ask whether family history plays a role. In many cases, doctors think these growths are more likely to come from changes that happen in blood vessel cells as the body develops, rather than from a gene change passed down from a parent. Rarely, genetics may matter more if there is a strong family history of intracranial structure hemangioma, several unusual blood vessel growths, or other findings that suggest a broader inherited condition. For many living with intracranial structure hemangioma, routine genetic testing is not a standard part of care unless that larger pattern is present. If your care team is concerned about an inherited cause, a genetics specialist can help explain whether testing is likely to be useful.
Is Intracranial structure hemangioma genetic?
Genetics do not appear to play a major role in intracranial structure hemangioma. Most cases seem sporadic rather than inherited, though rare genetic influences may be found in some people.
Having a genetic risk is not necessarily a diagnosis
Changes in genes are a normal part of human biology and are common across the general population. Most of these changes do not have a direct effect on health and are simply part of natural human diversity. For many genes, having a change linked to a condition suggests a possible association rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-studied change in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
When treatment is being planned, many people want to know how genetics affect treatment for intracranial structure hemangioma. For intracranial structure hemangioma, treatment is usually guided more by the hemangioma’s size, location, bleeding risk, and symptoms than by inherited genetic differences. Not every difference in response is genetic, but genes can sometimes affect how your body handles medicines used around care, such as some pain medicines or anti-seizure drugs. Genetic testing is not a routine part of choosing treatment for most people with intracranial structure hemangioma, and there are no widely used drug-gene tests that reliably select a medicine for the hemangioma itself. If side effects are unusual or standard doses do not seem to fit, a doctor may sometimes consider pharmacogenetic testing to improve safety, but for many living with intracranial structure hemangioma, the main plan still comes from imaging findings and a specialist’s judgment.
Interactions with other conditions
People living with intracranial structure hemangioma may also have symptoms that overlap with other brain or blood vessel conditions, which can make the cause of headaches, seizures, balance problems, or vision changes harder to sort out. If there is bleeding or pressure on nearby brain tissue, it can sometimes resemble a stroke, a brain tumor, or other vascular malformations, so doctors often need brain imaging to tell these apart. This connection brings us to how the condition interacts with others: blood-thinning medicines used for heart disease, stroke prevention, or blood clots may raise concern if the hemangioma has a risk of bleeding, although the decision depends on the size, location, and a person’s overall health. Many living with intracranial structure hemangioma also need careful follow-up if they have seizure disorders, since the hemangioma can trigger seizures and may affect which treatments are safest and most effective. Rarely, some people have more than one vascular condition in the brain, and family history can matter when doctors think about inherited forms. When new neurologic symptoms appear, it is important to look at the whole picture rather than assume intracranial structure hemangioma is the only cause.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Intracranial structure hemangioma?
Other growths or blood vessel problems inside the head can cause similar symptoms to an intracranial structure hemangioma, including common brain tumors such as meningioma, a tangle of abnormal blood vessels called an arteriovenous malformation, an aneurysm, or a cavernous malformation, which is a cluster of tiny fragile blood vessels. In some people, bleeding in the brain, stroke, or even severe migraine can also seem similar at first, especially if there is headache, vision change, weakness, or a seizure.
History
Long before modern brain scans existed, people living with unexplained headaches, seizures, vision changes, or balance problems often had no clear answer for what was causing them. In some cases, an intracranial structure hemangioma was only recognized during surgery or at autopsy, because these growths can sit deep within the skull and may not cause obvious signs until they press on nearby tissue or bleed.
Initially understood only through symptoms, later these lesions became easier to identify as pathology improved and doctors began comparing what they saw in the operating room with what people had experienced in daily life. Early medical reports often grouped different blood vessel growths together, so older descriptions were not always precise by today’s standards. That meant some cases were likely mislabeled or missed, especially when the lesion was small or in a hard-to-reach area.
The story changed sharply in the second half of the 20th century, when CT and then MRI gave doctors a way to see inside the skull without surgery. With these tools, many living with intracranial structure hemangioma could finally get a clearer explanation for symptoms that had once seemed unrelated, such as a seizure after years of good health or headaches that slowly became more frequent. These scans also helped specialists tell hemangiomas apart from other causes of a brain or skull mass.
In recent decades, awareness has grown as imaging, surgery, and laboratory study have all improved. Doctors now understand that intracranial structure hemangioma can look different depending on where it develops and how large it is, so the history of the condition is really a history of better recognition. Knowing that helps explain why early symptoms of intracranial structure hemangioma were once hard to connect to a single cause, and why diagnosis today is usually more accurate and much less uncertain than it used to be.